作者: M. J. O'Connell , I. C. Lavery , R. G. Gray , P. Quirke , D. J. Kerr
DOI: 10.1200/JCO.2010.28.15_SUPPL.3503
关键词:
摘要: 3503 Background: An understanding of biologic similarities and differences between st II III colon cancer is needed to inform clinical practice trial design. We compare pathologic markers a...